Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Uveal Melanoma × Radiotherapy × Clear all

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 26 Carcinoma, Non-Small-Cell Lung 26 Lung Neoplasms 21 Head and Neck Neoplasms 17 Lymphoma 15 Gliosarcoma 14 Squamous Cell Carcinoma of Head and Neck 13 Central Nervous System Neoplasms 13 Sarcoma 12 Esophageal Neoplasms 11 Glioma 10 Leukemia 9 Breast Neoplasms 9 Rectal Neoplasms 8 Prostatic Neoplasms 8 Brain Neoplasms 8 Pancreatic Neoplasms 7 Lymphoma, Follicular 6 Esophageal Squamous Cell Carcinoma 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Neoplasms 5 Neoplasm Metastasis 5 Melanoma 5 Lymphoma, Large B-Cell, Diffuse 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Carcinoma, Renal Cell 5 Astrocytoma 5 Adenocarcinoma of Lung 5 Uterine Cervical Neoplasms 4 Stomach Neoplasms 4

Interventions

Ipilimumab 5 Nivolumab 4 sargramostim 2 pembrolizumab 2 binimetinib 2 aldesleukin 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 trametinib 1 tebentafusp 1 sotrastaurin 1 montanide ISA 51 1 incomplete Freund's adjuvant 1 glembatumumab vedotin 1 fludarabine 1 entrectinib 1 Tramadol 1 Thalidomide 1 Temozolomide 1 Solutions 1 Ruthenium-106 1 Radiotherapy 1 RNA, Messenger 1 Protein Kinase C 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Interleukin-2 1 Ibuprofen 1 Cyclophosphamide 1 Crizotinib 1 Carmustine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05893654 2025-09-15

MELCOM

Hospital das Clínicas de Ribeirão Preto

Phase 1/2 Enrolling by invitation

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡